Clinical Trials Browser

INDUSTRY × Red-Cell Aplasia, Pure × Epoetin Alfa × Clear all

NCT00246597 2011-05-19

A Phase III Clinical Trial of PROCRIT (Epoetin Alfa) Versus Placebo in Women Undergoing Adjuvant Chemotherapy for Stage I, II or III Breast Cancer

Phase 3 Terminated

BreastClassical hematology

Anemia, Breast Neoplasms, Red-Cell Aplasia, Pure